InMed Pharmaceuticals Inc (INM) — Financial Flexibility Index
InMed Pharmaceuticals Inc (INM) has a Financial Flexibility Index of -3.60x as of June 2026. Free cash flow of $-7.03 Billion (operating CF $-7.03 Billion minus capex $5.49) represents -4% of total liabilities ($1.96 Billion). Check InMed Pharmaceuticals Inc (INM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
InMed Pharmaceuticals Inc Financial Flexibility Index (2001–2026)
Historical Financial Flexibility Index trend for InMed Pharmaceuticals Inc across 26 annual periods. For the full cash flow conversion analysis, see how efficiently does InMed Pharmaceuticals Inc generate cash.
Annual Financial Flexibility Index for InMed Pharmaceuticals Inc (2001–2026)
Year-by-year free cash flow to debt coverage for InMed Pharmaceuticals Inc. Explore InMed Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -4.42x | $-8.64 Billion | $-8.64 Billion | $1.96 Billion | ▼ -66.4% |
| 2025 | -2.66x | $-7.77 Million | $-7.77 Million | $2.92 Million | ▼ -36.3% |
| 2024 | -1.95x | $-6.98 Million | $-6.99 Million | $3.58 Million | ▲ +26.9% |
| 2023 | -2.67x | $-7.12 Million | $-7.28 Million | $2.67 Million | ▲ +18.1% |
| 2022 | -3.25x | $-15.54 Million | $-15.58 Million | $4.78 Million | ▲ +1.1% |
| 2021 | -3.29x | $-9.79 Million | $-9.79 Million | $2.97 Million | ▲ +13.6% |
| 2020 | -3.81x | $-7.33 Million | $-7.37 Million | $1.92 Million | ▲ +48.1% |
| 2019 | -7.34x | $-8.74 Million | $-8.77 Million | $1.19 Million | ▼ -44.1% |
| 2018 | -5.10x | $-3.63 Million | $-3.68 Million | $713.02K | ▲ +38.2% |
| 2017 | -8.25x | $-2.35 Million | $-2.37 Million | $284.24K | ▼ -877.4% |
| 2016 | -0.84x | $-385.19K | $-386.07K | $456.17K | ▲ +96.7% |
| 2015 | -25.64x | $-1.60 Million | $-1.61 Million | $62.51K | ▼ -181.1% |
| 2014 | -9.12x | $-639.35K | $-641.38K | $70.11K | ▼ -1042.9% |
| 2013 | -0.80x | $-39.26K | $-39.26K | $49.20K | ▲ +79.6% |
| 2012 | -3.92x | $-174.62K | $-174.62K | $44.59K | ▲ +67.8% |
| 2011 | -12.16x | $-562.05K | $-562.05K | $46.20K | ▼ -8272.6% |
| 2010 | -0.15x | $-195.42K | $-195.42K | $1.35 Million | ▼ -252.5% |
| 2009 | 0.10x | $100.48K | $100.48K | $1.05 Million | ▲ +115.6% |
| 2008 | -0.61x | $-926.30K | $-951.15K | $1.52 Million | ▲ +40.3% |
| 2007 | -1.02x | $-1.38 Million | $-1.40 Million | $1.35 Million | ▼ -101.2% |
| 2006 | -0.51x | $-577.40K | $-577.40K | $1.14 Million | ▼ -21.0% |
| 2005 | -0.42x | $-694.92K | $-702.23K | $1.66 Million | ▲ +30.0% |
| 2004 | -0.60x | $-468.75K | $-484.19K | $781.44K | ▲ +32.6% |
| 2003 | -0.89x | $-820.00K | $-844.62K | $921.99K | ▲ +94.1% |
| 2002 | -15.19x | $-1.13 Million | $-1.14 Million | $74.45K | ▼ -2661.5% |
| 2001 | 0.59x | $292.32K | $-471.69K | $493.02K | — |